200.14 USD
↗ 0.55 (0.27%)PRE MARKET (AS OF 05:12 AM EDT)
ABBVIE INC.
ABBVNYSE • USD
Market: OPEN
Open?$201.42
High?$201.50
Low?$200.51
Prev. Close?$200.95
Volume?1.3K
Avg. Volume?7.1M
VWAP?$201.05
Rel. Volume?0.00x
Bid / Ask
Bid?$200.00 × 100
Ask?$203.00 × 100
Spread?$3.00
Midpoint?$201.50
Valuation & Ratios
Market Cap?355.4B
Shares Out?1.8B
Float?1.8B
Float %?100.0%
P/E Ratio?84.71
P/B Ratio?-108.70
EPS?$2.37
Dividend?3.28%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.67Weak
Quick Ratio?0.56Weak
Cash Ratio?0.12Low
Debt/Equity?-20.64Low
ValuationFAIRLY VALUED
Score67/100
P/E?84.7PRICEY▾
P/B?-108.70CHEAP▾
P/S?5.81FAIR▾
P/FCF?20.0CHEAP▾
EV/EBITDA?14.9FAIR▾
EV/Sales?6.83HIGH▾
Returns & Efficiency
ROE?-128.3%WEAK▾
ROA?3.1%FAIR▾
Cash Flow & Enterprise
FCF?$17.8B
Enterprise Value?$417.7B
News
Profile
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Employees
57.0K
Market Cap
362.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-12-10
Address
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
Phone: (847) 932-7900
NORTH CHICAGO, IL 60064
Phone: (847) 932-7900